|
|
|
Live Tissue Bonding Technology
Tissue Welding
The tissue bonding / welding device is a platform technology that
bonds and reconnects living soft biological tissue through fusion
without the use of foreign matters or conventional wound closing
devices such as sutures, staples, sealant, or glues. The technology
leaves little or no scar tissue visible to the naked eye after a
few months. Unlike other tissue coagulation methods that tend to
destroy tissue by charring, searing and necrosis, the tissue welding
patented platform technology bonds and reconnects incised tissue
and avoids charring, searing and necrosis, using a low heat delivery
method aimed at restoration of the normal functions of the live
organs and tissue. The smokeless capability of the tissue welding
technology has a significant benefit to the medical professional
health services provider because current technologies for R F frequency
welding or bonding have significant smoke that the carcinogens have
been found carry infectious microorganisms from high risk HIV and
Hepatitis patients during surgery.
Three Ukraine hospitals are using the technology daily for open
and laparoscopic surgical procedures and techniques. The procedures
so far have involved the bonding and reconnecting of incised or
separated human tissues in the following body areas - nasal septum,
intestine, stomach, skin, gall bladder, liver, spleen, blood vessels,
nerves, alba linea, uterus, fallopian tube, ovary and testicles
- while restoring the normal function of the body organ.
The technology was invented and developed at the internationally
renowned "E. O. Paton Institute of Electric Welding", National Academy
of Sciences Ukraine headed by Professor B. E. Paton.
CSMG owns the exclusive world rights to the medical device platform
technology.
|
Tissue Bonding /
Welding Technology
|

Live Tissue Bonding Demonstration
|
|
|
|
| |
|
|
| Procedural Photos |
|
|
|
Pictured is a lung lobe portion remaining
in the body after resection by CSMG Technology's patented
tissue welding/bonding technology.
|
| |
|
|
|
|
|
The removed lung lobe portion after the
tissue welding/bonding process
|
|
CONTACT:
|
Donald S. Robbins
President and CEO
CSMG Technologies, Inc.
361-887-7546
K. Bruce Jones
770-955-0409
|
|